HLNCF:OTCMKTS
Haleon PLC
4,95 $
arrow_upward
+1,21%(+0,059) 1D
16 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
4,81 $
High
4,98 $
Low
4,81 $
Mkt. cap
44,32 մլրդ
Avg. vol.
10,03 հզր
Volume
17,69 հզր
52-wk high
5,75 $
52-wk low
4,15 $
Beta
-21,47
Shares outstanding
8,80 մլրդ
No. of employees
25 հզր
Open
4,81 $
High
4,98 $
Low
4,81 $
Mkt. cap
44,32 մլրդ
Avg. vol.
10,03 հզր
Volume
17,69 հզր
52-wk high
5,75 $
52-wk low
4,15 $
Beta
-21,47
Shares outstanding
8,80 մլրդ
No. of employees
25 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
4 ժամ առաջ
Goldman Sachs keeps Buy rating for Haleon stock at GBp 460.00
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC